SCHEMBL8294606

SCHEMBL8294606

CN(C)c1nc(-c2ccc(Oc3ccccc3)cc2)ncc1C(=O)O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.60
KMT2A Q03164 5/20 0.60
ALDH1A1 P00352 6/20 0.59
SMN1; SMN2 Q16637 2/20 0.59
TDP1 Q9NUW8 2/20 0.54
CYP1A2 P05177 2/20 0.49
POLB P06746 2/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
EGLN1 Q9GZT9 1/20 0.48
KDM4E B2RXH2 3/20 0.48
HTT P42858 1/20 0.48
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48
LMNA P02545 1/20 0.46
MGLL Q99685 1/20 0.45
HPGD P15428 2/20 0.44
DHODH Q02127 3/20 0.43
MCL1 Q07820 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8294634 0.88 ALDH1A1 (0.69) MEN1KMT2AALDH1A1SMN1; SMN2TDP1
SCHEMBL12929480 0.86 ALDH1A1 (0.83) MEN1KMT2AALDH1A1SMN1; SMN2CYP1A2
SCHEMBL8295375 0.78 ALDH1A1 (0.67) MEN1KMT2AALDH1A1SMN1; SMN2TDP1
SCHEMBL8297038 0.77 ALDH1A1 (0.74) MEN1KMT2AALDH1A1SMN1; SMN2CYP1A2
SCHEMBL12929707 0.77 ALDH1A1 (0.66) MEN1KMT2AALDH1A1SMN1; SMN2TDP1
SCHEMBL12929604 0.77 ALDH1A1 (0.66) MEN1KMT2AALDH1A1SMN1; SMN2TDP1
SCHEMBL12929439 0.77 MEN1 (0.72) MEN1KMT2AALDH1A1SMN1; SMN2TDP1
SCHEMBL5115261 0.75 MEN1 (1.00) MEN1KMT2AALDH1A1TDP1CYP1A2
SCHEMBL12929592 0.74 ALDH1A1 (0.70) MEN1KMT2AALDH1A1SMN1; SMN2TDP1
SCHEMBL8294641 0.74 ALDH1A1 (1.00) MEN1KMT2AALDH1A1SMN1; SMN2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005003099-A2 PYRIMIDINES USEFUL AS MODULATORS OF VOLTAGE-GATED ION CHANNELS VERTEX PHARMACEUTICALS INCORPORATED (US) 2005-01-13 WO disclosed